The International Working Group on Gaucher Disease (IWGGD Symposium), 2026
A symposium bringing together clinicians, researchers, patients, and industry representatives from around the world to discuss advances in Gaucher disease research and patient care.
Vpriv® (velaglucerase alfa)
- Bone mineral density improvements in velaglucerase alfa–treated patients with Gaucher disease: real-world evidence from the Gaucher Outcome Survey (GOS)